| Literature DB >> 30809438 |
Yan Li1,2, Ziyuan Zou3, Xiaohui Bian2, Yushan Huang2, Yanru Wang4, Chen Yang3, Jian Zhao2, Lang Xie1.
Abstract
BACKGROUND: Fecal microbiota transplantation (FMT) is an emerging therapy against Clostridium difficile infection (CDI) and inflammatory bowel disease (IBD). Although the therapy has gained prominence, there has been no bibliometric analysis of FMT.Entities:
Keywords: Bibliometric analysis; Citations; Clostridium difficile infection; Fecal microbiota transplantation; Inflammatory bowel disease
Year: 2019 PMID: 30809438 PMCID: PMC6387576 DOI: 10.7717/peerj.6411
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Figure 1Overview of article selection process.
Figure 2The number of annual publications (A), and growth trends of countries (B), the cooperation of countries/regions (C), growth trend of keywords (D) on FMT from 2004 to 2017.
Bibliometric information associated with the top 5 of the top 100 cited articles in FMT from 2004 to 2017.
| 1 | Van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent | 2013 | 1,158 | 231.60 | 1,307 | 261.40 |
| 2 | Vrieze A, Van N E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome [J]. Gastroenterology, 2012, 143(4):913–916. | 2012 | 738 | 123.00 | 800 | 133.33 |
| 3 | Surawicz C M, Brandt L J, Binion D G, et al. Guidelines for diagnosis, treatment, and prevention of | 2013 | 623 | 124.60 | 641 | 128.20 |
| 4 | Gough E, Shaikh H, Manges A R. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent | 2011 | 473 | 67.57 | 495 | 70.71 |
| 5 | Vétizou M, Pitt J M, Daillère R, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota [J]. Science, 2015, 350(6264):1079. | 2015 | 382 | 127.33 | 391 | 130.33 |
Figure 3Correlations between the number of citations and countries (A), institutions (B), the years since publication (C), and authors (D).
Figure 4Reference co-citation map (A), Network map of authors (B), Network map of co-cited authors (C) and Network map of institutions (D) contributed to publications on FMT from 2004 to 2017.
The top 5 journals of the top 100 articles ranked by the number of citation contributed to publications on FMT from 2004 to 2017.
| 1 | AMERICAN JOURNAL OF GASTROENTEROLOGY | the US | 10 | 10.231 |
| 2 | GASTROENTEROLOGY | the US | 8 | 20.773 |
| 3 | JOURNAL OF CLINICAL GASTROENTEROLOGY | the US | 8 | 2.975 |
| 4 | CLINICAL INFECTIOUS DISEASES | the US | 4 | 9.117 |
| 5 | CELL | the US | 3 | 31.398 |
The top five authors ranked by the number of articles.
| 1 | Kassam, Z | 38 | 325 | 4 | 186 | 1 | 7 |
| 2 | Khoruts, A | 33 | 755 | 6 | 153 | 9 | 202 |
| 3 | Kelly, CR | 24 | 375 | 5 | 243 | 8 | 297 |
| 4 | Sadowsky, MJ | 23 | 405 | 2 | 0 | 6 | 148 |
| 5 | Allegretti, JR | 22 | 22 | 5 | 4 | 1 | 0 |
The top five authors ranked by the number of citations.
| 1 | Khoruts, A | 33 | 755 | 6 | 153 | 9 | 202 |
| 2 | Brandt, LJ | 20 | 720 | 8 | 271 | 9 | 342 |
| 3 | de Vos, WM | 8 | 557 | 0 | 0 | 0 | 0 |
| 4 | Nieuwdorp, M | 18 | 509 | 0 | 0 | 9 | 171 |
| 5 | Zoetendal, EG | 4 | 472 | 0 | 0 | 0 | 0 |
The top five institutions ranked by the number of articles contributed to publications on FMT from 2004 to 2017.
| 1 | University of Minnesota, Gemini, Minnesota, the US | 99 | 1999 |
| 2 | University of washington, Seattle, Washington, the US | 58 | 1136 |
| 3 | McMaster University,ilton, Ontario, Canada | 34 | 1099 |
| 4 | Emory University, Atlanta, GA, the US | 32 | 119 |
| 5 | University of Alabama Birmingham, Birmingham, Alabama, the US | 30 | 58 |
Figure 5Visualization of two-dimensional knowledge map of keywords for the complete dataset.
Core Keywords related to FMT from 2004 to 2017.
| Infection | 16.79 | Clostridium difficile infection (171), infection (5), bacterial infections (4), refractory clostridium difficile infection (4), fulminant clostridium difficile infection (3) | |
| Inflammatory | 13.73 | Inflammatory bowel disease (66), ulcerative colitis (38), crohn’s disease (23), colitis (11), inflammation (8), pseudomembranous colitis (7) | |
| Diarrhea | 5.48 | Antibiotic-associated diarrhea (26), diarrhea (16), recurrent clostridium difficile infection (16), infectious diarrhea (3) | |
| Metabolism | 2.6 | Obesity (12), metabolic syndrome (9), diabetes (4), metabolism (4) | |
| Functional disease | 1.26 | Irritable bowel syndrome (11), functional bowel disease (3) | |
| Emotion | 0.63 | Depression (4), anxiety (3) | |
| Microbiota | 11.13 | Gut microbiota (49), microbiota (40), intestinal microbiata (27), bifidobacterium (5), lactobacillus (3) | |
| Environment | 2.69 | Dysbiosis (17), gut (4), rain-gut axis (3), gastrointestinal (3), gut permeability (3) | |
| Immunity | 0.81 | Immunomodulation (9) | |
| Subject | 2.42 | Children (13), germ-free (5), germ-free animals (3), mathematical modeling (3), mouse models (3) | |
| Method | 1.35 | 16s rRNA analysis (8), metagenomics (4), clinical trial (3) | |
| Transplantation | 33.3 | Fecal microbiota transplantation (301), microbiome (41), stool transplantation (9), bacterial consortium transplantation (7), bacteriotherapy (6), gut microbiome transplantation (4), transplantation (3) | |
| Food | 4.13 | Probiotics (33), prebiotic (8), diet (5) | |
| Antibiotics | 2.87 | Antibiotic therapy (13), fidaxomicin (6), vancomycin (6), metronidazole (4), infection control (3) | |
| Fibroptic endoscopy | 0.81 | Colonoscopy (9) |
The top 7 Keywords with the Strongest Citation Bursts on FMT from 2004 to 2017.
| flora | 2004 | 10.5588 | 2014 | ||
| bacteriotherapy | 2004 | 7.6856 | 2013 | ||
| diarrhea | 2004 | 7.0221 | 2013 | ||
| case series | 2004 | 6.2972 | 2013 | ||
| antibiotic associated diarrhea | 2004 | 5.4075 | 2013 | ||
| coliti | 2004 | 5.0701 | 2013 | ||
| enterocolitis | 2004 | 4.3316 | 2013 |